9.4

CVE-2018-14786

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.
Daten sind bereitgestellt durch National Vulnerability Database (NVD)
BdAlaris Gs Firmware Version <= 2.3.6
   BdAlaris Gs Version-
BdAlaris Gh Firmware Version <= 2.3.6
   BdAlaris Gh Version-
BdAlaris Cc Firmware Version <= 2.3.6
   BdAlaris Cc Version-
BdAlaris Tiva Firmware Version <= 2.3.6
   BdAlaris Tiva Version-
Zu dieser CVE wurde keine CISA KEV oder CERT.AT-Warnung gefunden.
EPSS Metriken
Typ Quelle Score Percentile
EPSS FIRST.org 7.32% 0.913
CVSS Metriken
Quelle Base Score Exploit Score Impact Score Vector String
nvd@nist.gov 9.4 3.9 5.5
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
nvd@nist.gov 7.5 10 6.4
AV:N/AC:L/Au:N/C:P/I:P/A:P
CWE-287 Improper Authentication

When an actor claims to have a given identity, the product does not prove or insufficiently proves that the claim is correct.